BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Huang XH, Sun LH, Lu DD, Sun Y, Ma LJ, Zhang XR, Huang J, Yu L. Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China. World J Gastroenterol 2003; 9(4): 692-695 [PMID: 12679912 DOI: 10.3748/wjg.v9.i4.692]
URL: https://www.wjgnet.com/1007-9327/full/v9/i4/692.htm
Number Citing Articles
1
Qianwei Ye, Sunbin Ling, Shusen Zheng, Xiao Xu. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNAMolecular Cancer 2019; 18(1) doi: 10.1186/s12943-019-1043-x
2
Emily Crowley, Federica Di Nicolantonio, Fotios Loupakis, Alberto Bardelli. Liquid biopsy: monitoring cancer-genetics in the bloodNature Reviews Clinical Oncology 2013; 10(8): 472 doi: 10.1038/nrclinonc.2013.110
3
Muhammad Nur Adam Hatta, Ezanee Azlina Mohamad Hanif, Siok-Fong Chin, Hui-min Neoh. Pathogens and Carcinogenesis: A ReviewBiology 2021; 10(6): 533 doi: 10.3390/biology10060533
4
Shu-Qiang Yue, Yan-Ling Yang, Ke-Feng Dou, Kai-Zong Li. Expression of PCNA and CD44mRNA in colorectal cancer with venous invasion and its relationship to liver metastasisWorld Journal of Gastroenterology 2003; 9(12): 2863-2865 doi: 10.3748/wjg.v9.i12.2863
5
Huai Wang, Peng Liao, Shelya X Zeng, Hua Lu. It takes a team: a gain-of-function story of p53-R249SJournal of Molecular Cell Biology 2019; 11(4): 277 doi: 10.1093/jmcb/mjy086
6
Jingjing Jiao, Weibo Niu, Ying Wang, Keith Baggerly, Yuanqing Ye, Xifeng Wu, Dewitt Davenport, Jose Luis Almeda, Monica M. Betancourt-Garcia, R. Armour Forse, Heather L. Stevenson, Gordon P. Watt, Joseph B. McCormick, Susan P. Fisher-Hoch, Laura Beretta. Prevalence of Aflatoxin-Associated TP53R249S Mutation in Hepatocellular Carcinoma in Hispanics in South TexasCancer Prevention Research 2018; 11(2): 103 doi: 10.1158/1940-6207.CAPR-17-0235
7
Filiz Türe Özdemir, Arzu Tiftikci, Seda Sancak, Fatih Eren, Veysel Tahan, Hakan Akın, Feyza Gündüz, Ala Eldeen Kedrah, Yücel Üstündağ, Erol Avşar, Nurdan Tözün, Osman Özdoğan. The Prevalence of the Mutation in Codon 249 of the P53 Gene in Patients with Hepatocellular Carcinoma (HCC) in TurkeyJournal of Gastrointestinal Cancer 2010; 41(3): 185 doi: 10.1007/s12029-010-9140-5
8
Peng Lee, Shilpa Jain, Matthew R. Pincus, Ruliang Xu. Henry's Clinical Diagnosis and Management by Laboratory Methods2011; : 1441 doi: 10.1016/B978-1-4377-0974-2.00076-2
9
S. Anitha, D. Raghunadharao, F. Waliyar, H. Sudini, M. Parveen, Ratna Rao, P. Lava Kumar. The association between exposure to aflatoxin, mutation in TP53, infection with hepatitis B virus, and occurrence of liver disease in a selected population in Hyderabad, IndiaMutation Research/Genetic Toxicology and Environmental Mutagenesis 2014; 766: 23 doi: 10.1016/j.mrgentox.2013.12.011
10
Vincent L. Chen, Neehar D. Parikh. Liquid Biopsy for Hepatocellular CarcinomaCurrent Hepatology Reports 2019; 18(4): 390 doi: 10.1007/s11901-019-00491-z
11
Ying-Hsiu Su, Selena Y Lin, Wei Song, Surbhi Jain. DNA markers in molecular diagnostics for hepatocellular carcinomaExpert Review of Molecular Diagnostics 2014; 14(7): 803 doi: 10.1586/14737159.2014.946908
12
Jia Jie Li, Yanqing Lv, Huifan Ji. Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysisPeerJ 2022; 10: e14303 doi: 10.7717/peerj.14303
13
GERALD C KIMBI, MICHAEL C KEW, MIMI C YU, KAZUKO ARAKAWA, JOHN HODKINSON. 249serp53 mutation in the serum of black southern African patients with hepatocellular carcinomaJournal of Gastroenterology and Hepatology 2005; 20(8): 1185 doi: 10.1111/j.1440-1746.2005.03951.x
14
Paul W. Ewald, Holly A. Swain Ewald. Infection, mutation, and cancer evolutionJournal of Molecular Medicine 2012; 90(5): 535 doi: 10.1007/s00109-012-0891-2
15
Jinmei Zhang, Yuan Yuan, Shuxia Gao, Xue Zhao, Hong Li. Diagnostic Performance of Circulating Cell-Free Dna for Hepatocellular Carcinoma: A Systematic Review and Meta-AnalysisBiomarkers in Medicine 2021; 15(3): 219 doi: 10.2217/bmm-2020-0334
16
Jian Zhou, Ao Huang, Xin-Rong Yang. Liquid Biopsy and its Potential for Management of Hepatocellular CarcinomaJournal of Gastrointestinal Cancer 2016; 47(2): 157 doi: 10.1007/s12029-016-9801-0
17
Michael Torbenson, Rajesh Kannangai, Susan Abraham, Fikret Sahin, Michael Choti, Jianzhou Wang. Concurrent Evaluation of p53, β-Catenin, and α-Fetoprotein Expression in Human Hepatocellular CarcinomaAmerican Journal of Clinical Pathology 2004; 122(3): 377 doi: 10.1309/YH0H3FKYM4RMU1JF
18
Jingjing Jiao, Weibo Niu, Ying Wang, Keith Baggerly, Yuanqing Ye, Xifeng Wu, Dewitt Davenport, Jose Luis Almeda, Monica M. Betancourt-Garcia, R. Armour Forse, Heather L. Stevenson, Gordon P. Watt, Joseph B. McCormick, Susan P. Fisher-Hoch, Laura Beretta. Prevalence of Aflatoxin-Associated TP53R249S Mutation in Hepatocellular Carcinoma in Hispanics in South TexasCancer Prevention Research 2018; 11(2): 103 doi: 10.1158/1940-6207.CAPR-17-0235
19
Kailas D Datkhile, Rashmi Gudur, Madhavi N Patil, Anand Gudur. Interactive Association of XRCC1, XRCC2, XRCC3, and TP53 Gene Polymorphisms With Gastrointestinal Cancer Risk: Insights From a Hospital-Based Case-Control StudyCureus 2024;  doi: 10.7759/cureus.61921
20
Fernanda Magri de Carvalho, Thiago de Almeida Pereira, Patrícia Lofego Gonçalves, Robson Dettmann Jarske, Fausto Edmundo Lima Pereira, Iuri Drumond Louro. Hepatocellular carcinoma and liver cirrhosis TP53 mutation analysis reflects a moderate dietary exposure to aflatoxins in Espírito Santo State, BrazilMolecular Biology Reports 2013; 40(8): 4883 doi: 10.1007/s11033-013-2587-2
21
Yunlong Cui, Hua Li, Hongjie Zhan, Tao Han, Yixuan Dong, Caijuan Tian, Yixian Guo, Fang Yan, Dong Dai, Pengfei Liu. Identification of Potential Biomarkers for Liver Cancer Through Gene Mutation and Clinical CharacteristicsFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.733478
22
Xiao-mo Wu, Jing-geng Fu, Wang-zhong Ge, Jiang-yan Zhu, Jun-yong Wang, Wei Zhang, Wei Qian, Ke-ke Huo. Screen p53 mutations in hepatocellular carcinoma by FASAY: A novel splicing mutationJournal of Zhejiang University SCIENCE B 2007; 8(2): 81 doi: 10.1631/jzus.2007.B0081
23
Xinghua Huang, Guoqing Ji, Yanhua Wu, Bo Wan, Long Yu. LAMA4, highly expressed in human hepatocellular carcinoma from Chinese patients, is a novel marker of tumor invasion and metastasisJournal of Cancer Research and Clinical Oncology 2008; 134(6): 705 doi: 10.1007/s00432-007-0342-6
24
Yan Liu, Chung-Chou H. Chang, Gary M. Marsh, Felicia Wu. Population attributable risk of aflatoxin-related liver cancer: Systematic review and meta-analysisEuropean Journal of Cancer 2012; 48(14): 2125 doi: 10.1016/j.ejca.2012.02.009
25
M. Fleischhacker, B. Schmidt. Circulating nucleic acids (CNAs) and cancer—A surveyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2007; 1775(1): 181 doi: 10.1016/j.bbcan.2006.10.001
26
Klaus Jung, Michael Fleischhacker, Anja Rabien. Cell-free DNA in the blood as a solid tumor biomarker—A critical appraisal of the literatureClinica Chimica Acta 2010; 411(21-22): 1611 doi: 10.1016/j.cca.2010.07.032
27
Y.M. Dennis Lo, Rossa W.K. Chiu. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics2012; : 1397 doi: 10.1016/B978-1-4160-6164-9.00045-7
28
Kabir Mody, Sean P. Cleary. A Review of Circulating Tumor DNA in Hepatobiliary MalignanciesFrontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00212
29
Sherif A. El-Kafrawy, Mohamed Abdel-Hamid, Mai El-Daly, Ola Nada, Alaa Ismail, Sameera Ezzat, Soheir Abdel-Latif, Amany Abdel-Hamid, Peter G. Shields, Christopher Loffredo. p53 Mutations in hepatocellular carcinoma patients in EgyptInternational Journal of Hygiene and Environmental Health 2005; 208(4): 263 doi: 10.1016/j.ijheh.2005.02.002
30
Katarzyna Szymañska, Jian-Guo Chen, Yan Cui, Yun Yun Gong, Paul Craig Turner, Stéphanie Villar, Christopher Paul Wild, Donald Maxwell Parkin, Pierre Hainaut. TP53 R249S Mutations, Exposure to Aflatoxin, and Occurrence of Hepatocellular Carcinoma in a Cohort of Chronic Hepatitis B Virus Carriers from Qidong, ChinaCancer Epidemiology, Biomarkers & Prevention 2009; 18(5): 1638 doi: 10.1158/1055-9965.EPI-08-1102
31
Rufina Igetei, Jesse A. Otegbayo, Dennis A. Ndububa, Olufunmilayo A. Lesi, Chiaka I. Anumudu, Pierre Hainaut, Emmanuelle Gormally. Detection of p53 codon 249 mutation in Nigerian patients with hepatocellular carcinoma using a novel evaluation of cell-free DNAAnnals of Hepatology 2008; 7(4): 339 doi: 10.1016/S1665-2681(19)31834-4
32
Jingjing Jiao, Jessica I. Sanchez, Erika J. Thompson, Xizeng Mao, Joseph B. McCormick, Susan P. Fisher-Hoch, P. Andrew Futreal, Jianhua Zhang, Laura Beretta. Somatic Mutations in Circulating Cell-Free DNA and Risk for Hepatocellular Carcinoma in HispanicsInternational Journal of Molecular Sciences 2021; 22(14): 7411 doi: 10.3390/ijms22147411
33
Gabriel D. Dakubo. Cancer Biomarkers in Body Fluids2017; : 247 doi: 10.1007/978-3-319-48360-3_8
34
S. Saleem, Z. A. Abbasi, A. Hameed, N. R. Qureshi, M. A. Khan, A. Azhar. Novel p53 codon 240 Ser > Thr coding region mutation in the patients of oral squamous cell carcinoma (OSCC)Tumor Biology 2014; 35(8): 7945 doi: 10.1007/s13277-014-2062-2
35
HORST H. SCHLECHTE, CORNELIA STELZER, SABINE WEICKMANN, MICHAEL FLEISCHHACKER, GUNTRAM SCHULZE. TP53 Gene in Blood Plasma DNA of Tumor PatientsAnnals of the New York Academy of Sciences 2004; 1022(1): 61 doi: 10.1196/annals.1318.011
36
V. B. Weeda, D. C. Aronson, J. Verheij, W. H. Lamers. Is hepatocellular carcinoma the same disease in children and adults? Comparison of histology, molecular background, and treatment in pediatric and adult patientsPediatric Blood & Cancer 2019; 66(2) doi: 10.1002/pbc.27475
37
K. Pandima Devi, B. Sivamaruthi, PV Kiruthiga, S. Karutha Pandian. Study of p53 codon 72 polymorphism and codon 249 mutations in Southern India in relation to age, alcohol drinking and smoking habitsHuman & Experimental Toxicology 2010; 29(6): 451 doi: 10.1177/0960327109354938
38
Ying-Hsiu Su, Amy K. Kim, Surbhi Jain. Liquid biopsies for hepatocellular carcinomaTranslational Research 2018; 201: 84 doi: 10.1016/j.trsl.2018.07.001